Neurogastrx Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$80M
- Investors
-
7
Neurogastrx General Information
Description
Developer of specialty therapies designed to treat gastrointestinal disorders affecting the enteric nervous system. The company's therapies address the unmet needs of functional and motility gastrointestinal disorders affecting gut contractions, sensation, and the brain-gut axis, enabling the medical community to satisfy the unmet patient needs and disease burden.
Contact Information
Website
neurogastrx.comCorporate Office
- 500 Unicorn Park Drive
- Suite 300
- Woburn, MA 01801
- United States
Corporate Office
- 500 Unicorn Park Drive
- Suite 300
- Woburn, MA 01801
- United States
Neurogastrx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 12-Jul-2021 | $80M | Completed | Clinical Trials - Phase 2 | ||
| 2. Later Stage VC (Series A) | 01-Aug-2018 | Completed | Clinical Trials - Phase 2 | |||
| 1. Seed Round | 12-Sep-2016 | $2.75M | $2.75M | Completed | Clinical Trials - Phase 2 |
Neurogastrx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed | 1,363,633 | $0.000100 | 6% | $0.55 | $0.55 | 1x | $0.55 | 0.67% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neurogastrx Comparisons
Industry
Financing
Details
Neurogastrx Competitors (11)
One of Neurogastrx’s 11 competitors is Alcresta Therapeutics, a Private Equity-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alcresta Therapeutics | Private Equity-Backed | Waltham, MA | ||||
| Novo Nordisk | Corporation | Bagsvaerd, Denmark | ||||
| Aries Pharmaceuticals | Corporation | San Diego, CA | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA |
Neurogastrx Patents
Neurogastrx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026080594-A1 | Metopimazine and its salts as adjunct therapy with glp-1 agonists | Pending | 09-Oct-2024 | ||
| EP-4271385-A1 | Methods of metabolizing metopimazine and its salts | Inactive | 29-Dec-2020 | ||
| EP-4271385-A4 | Methods of metabolizing metopimazine and its salts | Inactive | 29-Dec-2020 | ||
| US-20240156832-A1 | Methods of metabolizing metopimazine and its salts | Inactive | 29-Dec-2020 | ||
| WO-2022146970-A1 | Methods of metabolizing metopimazine and its salts | Inactive | 29-Dec-2020 | A61K31/5415 |
Neurogastrx Signals
Neurogastrx Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Marshall Wace | Hedge Fund | Minority | ||
| RTW Investments | Hedge Fund | Minority | ||
| Samsara BioCapital | Venture Capital | Minority | ||
| Vivo Capital | Venture Capital | Minority | ||
| 5AM Ventures | Venture Capital | Minority |
Neurogastrx FAQs
-
When was Neurogastrx founded?
Neurogastrx was founded in 2012.
-
Where is Neurogastrx headquartered?
Neurogastrx is headquartered in Woburn, MA.
-
What is the size of Neurogastrx?
Neurogastrx has 12 total employees.
-
What industry is Neurogastrx in?
Neurogastrx’s primary industry is Therapeutic Devices.
-
Is Neurogastrx a private or public company?
Neurogastrx is a Private company.
-
What is the current valuation of Neurogastrx?
The current valuation of Neurogastrx is .
-
What is Neurogastrx’s current revenue?
The current revenue for Neurogastrx is .
-
How much funding has Neurogastrx raised over time?
Neurogastrx has raised $128M.
-
Who are Neurogastrx’s investors?
Marshall Wace, RTW Investments, Samsara BioCapital, Vivo Capital, and 5AM Ventures are 5 of 7 investors who have invested in Neurogastrx.
-
Who are Neurogastrx’s competitors?
Alcresta Therapeutics, Novo Nordisk, Aries Pharmaceuticals, Pfizer Pakistan, and Ardelyx are some of the 11 competitors of Neurogastrx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process